Results 281 to 290 of about 1,097,417 (389)

Expert Review of the Strategies to Optimize Long-Term Outcomes After Coronary Artery Bypass Grafting. [PDF]

Rev Cardiovasc Med
Mokhtassi SS, Bulut HI, Salmasi Y, Khoshbin E.   +3 more
europepmc   +1 more source

Glycated Hemoglobin as a Predictor of the Length of Hospital Stay in Patients Following Coronary Bypass Graft Surgery in the Saudi Population

, 2019
Joud Almogati, Elnazeer O. Ahmed
openalex   +1 more source

Off-pump or on-pump coronary-artery bypass grafting at 30 days.

New England Journal of Medicine, 2012
A. Lamy, P. Devereaux, D. Prabhakaran, D. Taggart, Shengshou Hu, E. Paolasso, Z. Straka, L. Piegas, A. Akar, A. Jain, N. Noiseux, Chandrasekar Padmanabhan, J. Bahamondes, R. Novick, P. Vaijyanath, S. Reddy, L. Tao, P. Olavegogeascoechea, B. Airan, T. Sulling, R. Whitlock, Yongning Ou, J. Ng, S. Chrolavicius, S. Yusuf   +24 more
semanticscholar   +1 more source

Family quality‐of‐life burden in chronic spontaneous urticaria: A multicentre study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Poor control of chronic spontaneous urticaria (CSU) significantly worsens family members' quality of life, especially in emotional, physical, and social domains. Higher disease severity was linked to increased caregiving burden and household expenditures, highlighting the need for family‐centred CSU care and support across diverse global populations ...
Beatrice Martinez Zugaib Abdalla, Roberta Fachini Jardim Criado, Kanokvalai Kulthanan, Emek Kocatürk, Ivan Cherrez‐Ojeda, Ana Maria Giménez‐Arnau, Marcus Maurer, Luis Felipe Ensina, Jonathan A. Bernstein, Michihiro Hide, Sergio Duarte Dortas Junior, Solange Oliveira Rodrigues Valle, Gabriela Dias, Paraskevi Xepapadak, Priyanshi Dangi, Indrashis Podder, Vesna Trajkova, Natasa Teovska Mitrevska, Iman Hamed Nasr, Bushra Al Hinai, Joanna Bartosińska, Dorota Krasowska, Paulina Szczepanik‐Kułak, Hilal Gungor, Deniz Ozceker, Kübra Çiçek, Esen Özkaya, Yasemin Erdem, Mücahit Ergün, Mustafa Tosun, Rabia Oztas Kara, Jie Li, Anastasia Allenova, Paulo Ricardo Criado   +33 more
wiley   +1 more source

Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting: Insights From the CAMEO Registry. [PDF]

JACC Adv
Rymer JA, Page C, Alhanti B, Pichan C, Kansal A, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Wimmer NJ, Ang L, Bach R, Jenkins R, Brothers L, Jones WS, Washam JB, Wang TY, Narcisse DI, Basir MB, Chaturvedi A, Waksman R.   +20 more
europepmc   +1 more source

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

New England Journal of Medicine, 2016
Gregg W. Stone, J. Sabik, P. Serruys, C. Simonton, P. Généreux, J. Puskas, D. Kandzari, M. Morice, N. Lembo, W. M. Brown, D. Taggart, A. Banning, B. Merkely, F. Horkay, Piet W. Boonstra, A. V. van Boven, I. Ungi, G. Bogats, S. Mansour, N. Noiseux, M. Sabaté, J. Pomar, M. Hickey, A. Gershlick, P. Buszman, A. Bochenek, E. Schampaert, P. Pagé, O. Dressler, I. Kosmidou, R. Mehran, S. Pocock, A. Kappetein   +32 more
semanticscholar   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

Platelet-to-Hemoglobin Ratio in Predicting Major Adverse Cardiovascular Events After Coronary Artery Bypass Grafting. [PDF]

Vasc Health Risk Manag
Chen S, Zhang K, Liu X, Yang Z, Guan X, Zhou X, Xiao J, Li X, Jin J, Ma X, Li Q.   +10 more
europepmc   +1 more source

Retropubic ilio-iliac crossover bypass grafting in patients with hemilateral aorto-iliac occlusive disease.

, 1990
Han Yao
openalex   +2 more sources

Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder

Journal of Internal Medicine, EarlyView.
Abstract Gene therapy is emerging as a groundbreaking strategy for treating epilepsy, offering new hope to patients who do not respond to conventional medications. Despite advancements in anti‐seizure treatments, nearly 30%–40% of individuals with epilepsy continue to experience uncontrolled seizures, highlighting the urgent need for more effective and
Marco Ledri, Merab Kokaia
wiley   +1 more source